These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30707500)

  • 21. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy.
    Mehta SC; Lai JC; Lu DR
    J Microencapsul; 1996; 13(3):269-79. PubMed ID: 8860683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
    Haselsberger K; Radner H; Pendl G
    Neurosurgery; 1996 Aug; 39(2):321-5; discussion 325-6. PubMed ID: 8832669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
    Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
    Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boron neutron capture therapy of brain tumors: functional and neuropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Yang W; Barth RF; Rotaru JH; Boesel CP; Wilkie DA; Bresnahan JC; Hadjiconstantinou M; Goettl VM; Joel DD; Nawrocky MM
    J Neurooncol; 2000 Jul; 48(3):179-90. PubMed ID: 11100816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic secondary ion mass spectrometry analysis of boron from boron neutron capture therapy drugs in co-cultures: single-cell imaging of two different cell types within the same ion microscopy field of imaging.
    Lorey DR; Morrison GH; Chandra S
    Anal Chem; 2001 Aug; 73(16):3947-53. PubMed ID: 11534721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
    Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
    Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
    Kageji T; Nagahiro S; Otersen B; Gabel D; Nakaichi M; Nakagawa Y
    J Neurooncol; 2002 Sep; 59(2):135-42. PubMed ID: 12241106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy.
    Sun T; Li Y; Huang Y; Zhang Z; Yang W; Du Z; Zhou Y
    Oncotarget; 2016 Jul; 7(28):43095-43108. PubMed ID: 27191269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
    Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
    Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
    Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
    Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with
    Fukuda H
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
    Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
    Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
    Masunaga S; Nagasawa H; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Int J Hyperthermia; 2006 Jun; 22(4):287-99. PubMed ID: 16754350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot clinical study of boron neutron capture therapy for recurrent hepatic cancer involving the intra-arterial injection of a (10)BSH-containing WOW emulsion.
    Yanagie H; Higashi S; Seguchi K; Ikushima I; Fujihara M; Nonaka Y; Oyama K; Maruyama S; Hatae R; Suzuki M; Masunaga S; Kinashi T; Sakurai Y; Tanaka H; Kondo N; Narabayashi M; Kajiyama T; Maruhashi A; Ono K; Nakajima J; Ono M; Takahashi H; Eriguchi M
    Appl Radiat Isot; 2014 Jun; 88():32-7. PubMed ID: 24559940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenic effect of borocaptate sodium and boronophenylalanine in neutron capture therapy.
    Kinashi Y; Masunaga S; Ono K
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):562-7. PubMed ID: 12243836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M
    Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.